Tuberculous meningitis

Journal of Association of Physicians of India

Volumn 45, Issue 9, 1997, Pages 722-729

  Prasad, K ^a   Menon, Geetha R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2542565912     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Murray CJL, Feachem RG. Adult mortality in the developing world. Trans R Soc Trop Med 1990; 84 : 21-2.
2. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention. and cost Bull Int Union Tuberc Lung Dis 1990; 65 : 6-25.
3. Tandon PN, Bhatia R, Bhargava S. Tuberculous Meningitis. In : Handbook of Clinical Neurology (Revised Series). Vinken PJ, Bruyn GW, Klawans HL (eds). Elsevier Science Publishers, Amsterdam. 1988; 8 (52) : 195-226.
4. Jaeschke R, Guyatt G, Sackett DL. For the evidence based working group. Users guides to the medical literature III: how to use an article about a diagnostic test A : are the results of the study valid. JAMA 1994; 271 : 389-91.
5. Sackett DL, Haynes RB, Guyatt GH, Tugwell P, Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, Mass: Little Brown and Co Inc. 1991; 145-8.
6. Guyatt GH, Tugwell P, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. Can Med Assoc J 1986; 134 : 587-94.
7. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology- The Essentials. Baltimore, Williams and Wilkins. 1988; 42-75.
8. Kadival GV, Mazarelo TBMS, Chaparas SD. Sensitivity and specificity of enzyme linked immunosorbent assay in the detection of antigen in tuberculous Meningitis cerebrospinal fluids. J Clin Microbiol 1986; 23 : 901-4.
9. Ashtekar MD, Dhalla AS, Mazarello TBMS, Samuel AM. A study of Mycobacterium tuberculosis antigen and antibody in cerebrospinal fluid and blood in tuberculous meningitis. Clin Immunol Immunopathol 1987; 45 : 29-34.
10. Chandramuki A, Bothamley GH, Brennan PJ, Ivanyi J. Levels of antibody to defined antigens of mycobacterium tuberculosis in tuberculous meningitis. J Clin Microbiol 1989; 27 : 821-25.
11. Behari M, Raj M, Ahuja GK, Shrinivas. Soluble antigen fluorescent antibody test in the serodiagnosis of tuberculous meningitis. J Assoc Phys India 1989; 37 : 499-501.
12. Shankar P, Manjunath N, Mohan KK, Prasad K, Behari M, Shriniwas, Ahuja GK. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991; 337 : 5-7.
13. Desai T, Gogate A, Deodhar L, Toddywalla S, Kelkar M. Enzyme linked immunosorbent assay for antigen detection in tuberculous meningitis. Indian J Pathol Microbiol 1993; 36 : 348-55.
14. Schulzer M, Anderson DR, Drance SM. Sensitivity and specificity of a diagnostic test determined by repeated observations in the absence of an external standard. J Clin Epidemiol 1991; 41 : 1167-79.
15. Ahuja GK, Mohan KK, Prasad K, Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tubercle Lung Dis 1994; 75 : 149-52.
16. Ellner JJ, Hinman AR, Dooley SW, et al. Tuberculosis symposium: emerging problem and promise. J Infect Dis 1993; 168 : 535-7.
17. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with human immunodeficiency virus. N Engl J Med 1992; 326 : 668-72.
18. Laguna F, Adrados M, Ortega A, Gonzales-Lahoz JM. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS 1992; 6 : 1165-7.
19. Bishburg E, Sunderam G, Rechman LB, Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 1986; 105 : 210-3.
20. Monno L, Angarano G, Romanelli C, et al. Polymerase chain reaction for non-invasive diagnosis of brain mass lesions caused by Mycobacterium tuberculosis : report of five cases in human immunodeficiency virus-positive subjects. Tubercle Lung Dis 1996; 77 : 280-4.
21. Venkataraman S, Dhamija RM, Rana PVS. Tuberculous meningitis. Proc Med Update 1991; 3 : 200-13.
22. Sodhani P, Singh NK, Thacker AK, Katiyar BC, Misra S. Intrathecal hyaluronidase therapy in tuberculous arachnoiditis. J Assoc Phys India 1986; 34 : 636-8.
23. Gourie-Devi M, Satishchandra P. Hyaluronidase as an adjuvant in the management of tuberculous spinal arachnoiditis. J Neurol Sci 1991; 102 : 105-11.
24. Ramchandran P, Duraipandian M, Nagarajan R, Prabhakar R, Ramakrishnan CV, Tripathy SP. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986; 67 : 17-29.
25. Alarcon F, Escalante Luis, Perez Yanira, Banda Hector, Chacon Gonzalo, Duenas Gonzalo. Tuberculous meningitis - Short course of chemotherapy. Arch Neurol 1990; 47 : 1313-7.
26. Jacobs RF, Sunakon Pramuan, Chotpitayasunonah Tawee, Pope Sandra, kelleher Kelly. Intensive short course chemotherapy for tuberculous meningitis. Pediatr Infect Dis J 1992; 11 : 194-8.
27. Girgis NI, Fand Zoheir, Kilpatrick ME, Sultan Yehia, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991; 10 : 179-83.
28. Kumarvelu S, Prasad K, Khosla A, Behari M, Ahuja GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tubercle Lung Dis 1994; 75 : 203-7.
29. Guyatt GH, Sackett DL, Cook DJ. For the Evidence-Based Working Group. Users' guides to the medical literature, II : How to use an article about therapy or prevention, A : are the results of the study valid? JAMA 1993; 270 : 2598-601.
30. Chandersekharan S, Chauhan MM, Rajalakshmi R, Chaudhuri K, Mahadev B. Initial drug resistance to anti-tuberculosis drugs in patients attending urban district tuberculosis centre, Ind J Tuberculosis 1990; 37 : 215-6.
31. Trivedi SS, Desai SG. Primary anti-tuberculosis drug resistance and acquired rifampicin resistance in Gujarat, India Tubercle 1988; 64 : 37-42.
32. Hong Kong Chest Service/British Medical Research Council. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1987; 136 : 1339-42.
33. Hong Kong Chest Service/British Medical Research Council. Contro Hed trial of 2,4 and 6 months of pyrazinamide in 6-month, three-times weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide. Am Rev Respir Dis 1991; 143 : 700-6.
34. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133 : 423-30.